Showing 1091-1100 of 5301 results for "".
Thin Melanomas: When is SLN Biopsy Indicated?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thin-melanomas-when-is-sln-biopsy-indicated/20805/New research offers additional evidence that mitotic rate may have a role in clinical decision-making.Statins and Skin Cancer: The Latest Data
https://practicaldermatology.com/topics/skin-cancer-photoprotection/statins-and-skin-cancer-the-latest-data/20426/A look at another commonly used drug and its potential association with skin cancer risks.A Novel Topical Cream to Reduce Bruising
https://practicaldermatology.com/topics/general-topics/a-novel-topical-cream-to-reduce-bruising/21476/Although options to treat bruising have been limited, a new cream may be especially useful for older patients.Injectable Aesthetic Treatments for Immediate and Regenerative Results
https://practicaldermatology.com/issues/october-2025/injectable-aesthetic-treatments-for-immediate-and-regenerative-results/39759/Injectable treatments remain central to aesthetic medicine because they can deliver immediate improvement while also stimulating regenerative changes that enhance long-term outcomes. The following overview highlights several key agents and combinations currently used to balance short-term correctionTNF Inhibitors and the Risk of Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tnf-inhibitors-and-the-risk-of-melanoma/21519/New research offers a deeper look into the potential elevated risk for malignant melanoma from TNF treatment.Let’s Talk About Truncal Acne
https://practicaldermatology.com/topics/acne-rosacea/lets-talk-about-truncal-acne/23785/A look at the burden of truncal acne and current treatment options.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Lose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Examining the Emotional Impact of Acne in a Virtual World
https://practicaldermatology.com/columns/clinical-focus-1/examining-the-emotional-impact-of-acne-in-a-virtual-world/23577/Acne patients are working hard to conceal their acne on Zoom.D as in Delta: The Changing Views on Vitamin D in Dermatology
https://practicaldermatology.com/topics/atopic-dermatitis/d-as-in-delta-the-changing-views-on-vitamin-d-in-dermatology/23616/Evidence suggests that vitamin D supplementation may benefit some patients with AD.